Form 8-K - Current report:
SEC Accession No. 0001559053-22-000017
Filing Date
2022-04-26
Accepted
2022-04-26 08:32:33
Documents
14
Period of Report
2022-04-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20220426.htm   iXBRL 8-K 41032
2 EX-99.1 exhibit991prx012fasttrackp.htm EX-99.1 13559
6 GRAPHIC image_0a.jpg GRAPHIC 6226
  Complete submission text file 0001559053-22-000017.txt   212637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20220426.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20220426_lab.xml EX-101.LAB 25750
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20220426_pre.xml EX-101.PRE 13636
8 EXTRACTED XBRL INSTANCE DOCUMENT prta-20220426_htm.xml XML 12021
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 22851884
SIC: 2834 Pharmaceutical Preparations